Novartis in Advanced Talks to Buy Cytokinetics 
 

Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug.

 
FAA Approves Inspection Method for Grounded 737 MAX 9 Jets 
 

The agency has approved procedures for airlines to inspect their grounded 737 MAX 9 jets, clearing the way for the planes to return to service.

 
Tiger Woods and Nike Split Up After 27 Years 
 

The 15-time major golf champion had one of the longest, and most lucrative, endorsement deals in sports.

 
Apple's Vision Pro to Become Available In U.S. Feb. 2 
 

Apple's new mixed-reality headset will become available in the U.S. starting Feb. 2, setting the stage for the company's premium-priced offering to compete in a crowded market.

 
Bank of America Recognizes $1.6 Billion Charge on Discontinuation of Loan Index 
 

The charge was related to the discontinuation of an alternative reference rate, the Bloomberg Short-Term Bank Yield Index.

 
Twilio's stock up more than 6% as CEO Jeff Lawson steps down 
 

The surprise move comes as the enterprise-communications software company battles two activist investors pushing for big changes at Twilio.

 
Boston Scientific to Acquire Axonics For About $3.7 Billion 
 

Axonics had agreed to be bought for $71 a share. Boston Scientific said the deal gave Axonics an equity value of $3.7 billion and an enterprise value of $3.4 billion.

 
Johnson & Johnson to Acquire Ambrx for $2 Billion 
 

Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal.

 
Newell Brands to Cut 7% of Office Roles, Reduce Footprint 
 

Newell Brands will slash about 7% of its office roles and pare down its real-estate footprint in an organizational realignment.

 
Merck to Buy Harpoon Therapeutics for $680 Million 
 

Merck has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million.

(END) Dow Jones Newswires

January 08, 2024 13:15 ET (18:15 GMT)